Ross Bray
Impact in
-
- Diabetes Treatment and Management
- Diet, Metabolism, and Disease
- Diabetes Management and Research
- Pharmacology top 2%
- Pharmacology and Obesity Treatment
Papers in
-
- Diabetes Treatment and Management 9
- Diabetes Management and Research 2
-
- Metabolism, Diabetes, and Cancer 4
- Co-authors
- Ángel Rodríguez (11 shared papers)Laura Fernández Landó (9 shared papers)Juan P. Frías (5 shared papers)Axel Haupt (6 shared papers)Deborah A. Robins (6 shared papers)Hiren Patel (3 shared papers)Yukiko Onishi (1 shared paper)Dominik Dahl (1 shared paper)
- Journals
- Diabetes (5 papers)Diabetes Obesity and Metabolism (3 papers)Therapeutic Innovation & Regulatory Science (2 papers)The Lancet Diabetes & Endocrinology (2 papers)Statistics in Biopharmaceutical Research (1 paper)
- Partner nations
- United StatesGermanySpain
In The Last Decade
Ross Bray
22 papers receiving 2.0k citations
Ross Bray's Hit Papers
Peers
Comparison fields: 5 of 73
- Endocrinology, Diabetes and Metabolism 1.3k
- Pharmacology 385
- Physiology 337
- Epidemiology 392
- Hepatology 63
Countries citing papers authored by Ross Bray
This map shows the geographic impact of Ross Bray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ross Bray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ross Bray more than expected).
Fields of papers citing papers by Ross Bray
This network shows the impact of papers produced by Ross Bray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ross Bray. The network helps show where Ross Bray may publish in the future.
Co-authors
The 25 scholars most cited alongside Ross Bray, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial Hit paper breakdown → | 2021 | 447 |
| 2 | Effect of Subcutaneous Tirzepatide vs Placebo Added to Titrated Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes Hit paper breakdown → | 2022 | 418 |
| 3 | Effect of tirzepatide versus insulin degludec on liver fat content and abdominal adipose tissue in people with type 2 diabetes (SURPASS-3 MRI): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial Hit paper breakdown → | 2022 | 355 |
| 4 | Effects of Novel Dual GIP and GLP-1 Receptor Agonist Tirzepatide on Biomarkers of Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes Hit paper breakdown → | 2020 | 281 |
| 5 | Dual GIP and GLP-1 Receptor Agonist Tirzepatide Improves Beta-cell Function and Insulin Sensitivity in Type 2 Diabetes Hit paper breakdown → | 2020 | 241 |
| 6 | 2020 | 178 | |
| 7 | Tirzepatide and muscle composition changes in people with type 2 diabetes (SURPASS-3 MRI): a post-hoc analysis of a randomised, open-label, parallel-group, phase 3 trial Hit paper breakdown → | 2025 | 35 |
| 8 | 2023 | 22 | |
| 9 | 2024 | 21 | |
| 10 | 2022 | 16 | |
| 11 | 2023 | 10 | |
| 12 | 2019 | 5 | |
| 13 | 2021 | 5 | |
| 14 | 2019 | 4 | |
| 15 | 2022 | 3 | |
| 16 | 2019 | 2 | |
| 17 | 2023 | 1 | |
| 18 | Statistics of Solar Seeing | 1966 | 1 |
| 19 | 2021 | 1 | |
| 20 | 2022 | 1 |
About Ross Bray
Ross Bray is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology, Pharmacology, Epidemiology and Statistics and Probability, having authored 22 papers that have together received 2.0k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (9 papers), Metabolism, Diabetes, and Cancer (4 papers), Pharmacology and Obesity Treatment (4 papers), Liver Disease Diagnosis and Treatment (3 papers), Diabetes Management and Research (2 papers), Statistical Methods in Clinical Trials (2 papers), Folate and B Vitamins Research (1 paper) and Advanced Causal Inference Techniques (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.3k citations), Pharmacology (385 citations), Physiology (337 citations), Epidemiology (392 citations) and Hepatology (63 citations). Ross Bray has collaborated with scholars based in United States, Germany and Spain. Frequent co-authors include Ángel Rodríguez, Laura Fernández Landó, Juan P. Frías, Axel Haupt, Deborah A. Robins, Hiren Patel, Yukiko Onishi, Dominik Dahl, Paul Norwood and Ruth Huh. Their work appears in journals such as Diabetes, Diabetes Obesity and Metabolism, Therapeutic Innovation & Regulatory Science, The Lancet Diabetes & Endocrinology and Statistics in Biopharmaceutical Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.